Everolimus showed efficacy in reducing angiomyolipoma lesion volume in patients with SEGA associated with TSC.The trial is registered with ClinicalTrials.gov , number NCT@ ; http://clinicaltrials.gov/ct@/show/NCT@?term=EXIST-@&rank=@ .